MWAM
NVO

Manhattan West Asset Management’s Novo Nordisk NVO Stock Holding History

Manhattan West Asset Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.03M Sell
42,249
-416
-1% -$17.9K 0.34% 62
2026
Q1 		$1.57M Buy
42,665
+10,854
+34% +$514K 0.31% 67
2025
Q4 		$1.62M Sell
31,811
-8,558
-21% -$438K 0.33% 66
2025
Q3 		$2.24M Buy
40,369
+11,278
+39% +$660K 0.47% 56
2025
Q2 		$2.01M Buy
+29,091
New +$1.98M 0.46% 57

Other funds holding NVO

Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Manhattan West Asset Management's NVO Position: Q2 2026 in Review

Manhattan West Asset Management reduced its Novo Nordisk (NVO) stake by 0.98% in Q2 2026, selling an estimated $17.9K and leaving 42,249 shares worth $2.03M. The position accounts for 0.34% of the portfolio, ranked #62.

Manhattan West Asset Management first reported a position in NVO in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.24M in Q3 2025. 1,356 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Manhattan West Asset Management held 42,249 shares of Novo Nordisk worth $2.03M as of Q2 2026.
  • Manhattan West Asset Management sold 416 Novo Nordisk shares in Q2 2026, an estimated $17.9K.
  • Novo Nordisk made up 0.34% of Manhattan West Asset Management's portfolio in Q2 2026, its #62 holding.
  • Manhattan West Asset Management first reported a position in Novo Nordisk in Q2 2025 and has held it in 5 quarters since.
  • Manhattan West Asset Management's Novo Nordisk position peaked at $2.24M in Q3 2025.
  • 1,356 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Manhattan West Asset Management's 13F filing for Q2 2026, filed 11 Aug 2026.